Table 2 Variable distributions: results from the analysis of primary and secondary outcomes

From: Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trial

 

Decision aid (n = 68)

Genetic counselor (n = 65)

Intervention vs. control Between group difference (95% CI)

Significance

Mean (SD)

Mean (SD)

 

Baseline

After DA (T1)

After DA + GC (T2)

Baseline

After GC (T1)

T1 vs. T1

T2 vs. T1

T1 vs. T1

T2 vs. T1

Decisional conflict (1–5)

1.87 (0.71)

1.77 (0.69)

1.71 (0.54)

0.15 (−0.06 to 0.36)

0.05 (−0.15 to 0.27)

0.16

0.60

Decisional conflict adjusted score (0–100)

21.67 (17.77)

19.25 (17.16)

 

17.84 (13.51)

−3.83 (−9.23 to 1.57)

−1.41 (−6.75 to 3.93)

0.16

0.60

Knowledge of secondary findings (0–5)

4.92 (0.32)

4.93 (0.26)

4.54 (0.81)

0.39 (0.18 to 0.59)

<0.001

Knowledge: sequencing limitations (1–10)

5.85 (2.53)

7.32 (2.53)

7.41 (2.46)

5.75 (2.74)

7.14 (2.74)

0.12 (−0.67 to 0.86)

0.14 (−0.61 to 0.89)

0.73

0.70

Knowledge: sequencing benefits (1–10)

5.12 (2.00)

7.07 (2.19)

7.06 (2.12)

5.08 (1.97)

6.09 (2.47)

1.00 (0.26 to 174)

0.97 (0.22 to 0.95)

0.01

0.01

Preparation for decision-making (0–100)

74.38 (17.46)

76.06 (16.74)

76.23 (18.44)

1.86 (-4.31 to 8.02)

0.17 (−5.92 to 6.26)

0.55

0.95

Satisfaction with decision (6–30)

21.79 (7.95)

24.55 (5.54)

22.37 (7.71)

0.58 (−2.11 to 3.26)

−2.18 (−4.5 to 0.15)

0.60

0.06

State–Trait Anxiety Inventory (20–80)

28.97 (11.16)

27.90 (9.72)

26.06 (9.14)

31.02 (12.45)

27.03 (9.64)

2.22 (−0.34 to 4.79)

0.72 (−1.73 to 3.18)

0.89

0.56

Time with genetic counselor (minutes)

16.15 (9.20)

40.55 (9.11)

24.40 (27.72 to −21.07)

<0.001

  
  1. CI confidence interval, DA decision aid, GC genetic counseling.